Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the..